Teva Pharmaceutical Industries Limited (TEVJF)

Market Cap	32.65B
Revenue (ttm)	16.78B
Net Income (ttm)	713.00M
Shares Out	n/a
EPS (ttm)	0.62
PE Ratio	45.79
Forward PE	10.83
Dividend	n/a
Ex-Dividend Date	n/a

Volume	100
Average Volume	431
Open	26.00
Previous Close	18.50
Day's Range	26.00 - 26.00
52-Week Range	13.73 - 26.00
Beta	0.70
RSI	65.54
Earnings Date	Jan 28, 2026

About TEVJF

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The com...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1901
• Employees: 35,686
• Stock Exchange: OTCMKTS
• Ticker Symbol: TEVJF

Financial Performance

In 2024, TEVJF's revenue was $16.54 billion, an increase of 4.40% compared to the previous year's $15.85 billion. Losses were -$1.64 billion, 193.2% more than in 2023.